CD274 and breast carcinoma: Next, we investigated whether SCCNV injection could suppress the metastatic growth of 4T1-Luc breast cancer cells, and anti-programmed death-ligand 1 (PD-L1) antibodies were administered to assess combination therapy (Fig. 7a).